Posttransplant lymphoproliferative disorder resembling a chronic orocutaneous infection in an immunosuppressed patient

Journal of Oral and Maxillofacial Surgery

Volumn 62, Issue 8, 2004, Pages 1033-1037

  Steinberg, Mark J ^a,b   Herrera, Andrés F ^a   Barakat, Rodrigue G ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b 2160 S First Ave ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MONOCLONAL ANTIBODY;

AGED; ANAMNESIS; ANTIBIOTIC THERAPY; ARTICLE; CANDIDA GLABRATA; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DEBRIDEMENT; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOPROLIFERATIVE DISEASE; MALE; MICROORGANISM DETECTION; MOUTH INFECTION; OSTEOMYELITIS; PANORAMIC RADIOGRAPHY;

AGED; CUTANEOUS FISTULA; DIAGNOSIS, DIFFERENTIAL; FACIAL NEOPLASMS; HEART TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC; MALE; ORAL FISTULA; POSTOPERATIVE COMPLICATIONS; SKIN NEOPLASMS;

EID: 3242733297     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2003.07.010     Document Type: Article

References (16)

1. Nalesnik M.A., Demetris A.J., Fung J.J., et al. Lymphoproliferative disorders arising under immunosuppression with FK 506 Initial observations in a large transplant population. Transplant Proc. 23:(1 Pt 2):1991;1108
2. Ho M., Jaffe R., Miller G., et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation. 45:1988;719
3. Reding R., Wallemacq P.E., Lamy M.E., et al. Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Efficacy, toxicity, and dose regimen in 23 children. Transplantation. 57:1994;93
4. Levine S.M., Angel L., Anzueto A., et al. A low incidence of post transplant lymphoproliferative disorder in 109 lung transplant recipients. Chest. 116:1999;1273
5. Walker R.C., Paya C.V., Marshall W.F., et al. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for post transplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant. 14:1995;214
6. Myer C.M. 3rd, Reilly J.S. Airway obstruction in an immunosuppressed child. Arch Otolaryngol. 111:1985;409
7. Fairley J.W., Hunt B.J., Glover G.W., et al. Unusual lymphoproliferative oropharyngeal lesions in heart and heart-lung transplant recipients. J Laryngol Otol. 104:1990;720
8. Broughton S., McClay J.E., Murray A., et al. The effectiveness of tonsillectomy in diagnosing lymphoproliferative disease in pediatric patients after liver transplantation. Arch Otolaryngol Head Neck Surg. 126:2000;1444
9. Sokal E.M., Antunes H., Beguin C., et al. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus. Transplantation. 27:1997;1438
10. Dror Y., Greenberg M., Taylor G., et al. Lymphoproliferative disorders after organ transplantation in children. Transplantation. 15:1999;990
11. Huang R.Y., Shapiro N.L. Adenotonsillar enlargement in pediatric patients following solid organ transplantation. Arch Otolaryngol Head Neck Surg. 126:2000;159
12. Reding R., Wallemacq P.E., Lamy M.E., et al. Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Efficacy, toxicity, and dose regimen in 23 children. Transplantation. 57:1994;93
13. Reyes J., Tzakis A.G., Bonet H., et al. Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. Transplant Proc. 26:1994;1426
14. Hanto D.W., Frizzera G., Gajl-Peczalska K.J., et al. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation. 39:1985;461
15. Davis C.L., Wood B.L., Sabath D.E., et al. Interferon-alpha treatment of post transplant lymphoproliferative disorder in recipients of solid organ transplants. Transplantation. 27:1998;1770
16. Reynaud-Gaubert M., Stoppa A.M., Gaubert J., et al. Anti-CD20 monoclonal antibody therapy in Epstein-Barr virus-associated B cell lymphoma following lung transplantation. J Heart Lung Transplant. 19:2000;492